{"id":448,"date":"2019-05-08T15:56:06","date_gmt":"2019-05-08T13:56:06","guid":{"rendered":"https:\/\/idibell.cat\/?page_id=448"},"modified":"2024-04-11T08:14:00","modified_gmt":"2024-04-11T06:14:00","slug":"programa-de-mecanismes-molleculars-i-terapia-experimental-en-oncologia-oncobell","status":"publish","type":"page","link":"https:\/\/idibell.cat\/recerca\/area-de-cancer\/programa-de-mecanismes-molleculars-i-terapia-experimental-en-oncologia-oncobell\/","title":{"rendered":"Programa de Mecanismes Mol\u00b7leculars i Ter\u00e0pia Experimental en Oncologia (Oncobell)"},"content":{"rendered":"\n

\n\t\tPrograma de Mecanismes Moleculars i Ter\u00e0pia Experimental en Oncologia (Oncobell)\n\t<\/h1>\n

\n\t\tResum\n\t<\/h3>\n\t

La recerca desenvolupada pels diferents grups del programa cobreix la major part de les etapes investigadores, des de la recerca b\u00e0sica a l’aplicaci\u00f3 cl\u00ednica. La millora del pron\u00f2stic del pacient \u00e9s un objectiu com\u00fa a qu\u00e8 s’intenta arribar o b\u00e9 des de l’estudi a nivell molecular i de rutes de senyalitzaci\u00f3, \u00a0o b\u00e9 a trav\u00e9s de la definici\u00f3 de necessitats cl\u00edniques no resoltes per a cada malaltia. La interacci\u00f3 entre aquests dos enfocaments dona lloc a millors idees i accelera el proc\u00e9s de transfer\u00e8ncia del laboratori a la cl\u00ednica. L’organitzaci\u00f3 del programa tamb\u00e9 busca expandir la xarxa de contactes tant a nivell intern com extern per tal d’optimitzar les capacitats de recaptaci\u00f3 de fons i l’impacte cient\u00edfic de la recerca de l’IDIBELL.<\/p>\n\t\t\t\t\"white-blood-cell-cell-blood-cell-blood-45239\"\n\t

El programa de mecanismes moleculars i ter\u00e0pia experimental en oncologia de l’IDIBELL agrupa diversos equips de recerca per combatre el c\u00e0ncer de manera multidisciplin\u00e0ria<\/p>\n

21<\/h2>\n

Grups<\/h2>\n

94<\/h2>\n

Investigadors principals<\/h2>\n

\n\t\tGrups de Recerca\n\t<\/h3>\n\t\t\t\t\n\t\t\t\t\"colorectal_adenocarcinoma_cytology_intermed_mag-e1587739500516\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tGrup Moreno & Salazar\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tC\u00e0ncer Colorectal\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"108-mortcelular-cmunozpinedo-def\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tGrup Mu\u00f1oz-Pinedo & Nadal\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tRecerca precl\u00ednica i experimental dels tumors tor\u00e0cics (PReTT)\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"neuroblastoma_rosettes\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tGrup Gil\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tApoptosi i C\u00e0ncer \n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"110-tgfbetacancer-fabregat-def\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tGrup Fabregat\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tTGF-Beta i C\u00e0ncer\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"all_-_peripherial_blood_-_diagnosis_-_01\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tGrup Sureda\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tTumors Hematopo\u00e8tics i Limfoides\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"112-sarcoma-omteztirado-def\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tGrup Mart\u00ednez-Tirado\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tSarcoma\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"113-radiobiologiacancer-guedea-def\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tGrup Guedea\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tRadiobiologia i C\u00e0ncer\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"114-cancerhereditari-capella-2def_2\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tGrup Capell\u00e1 & L\u00e1zaro\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tC\u00e0ncer Hereditari\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"metabolism-and-cancer3s\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tGrup Thomas\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tMetabolisme i C\u00e0ncer\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"511-malaltiescapcoll-mmanos-def\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tGrup Ma\u00f1os\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tMalalties de cap i coll\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"119-neurooncologia-jbruna-def\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tGrup Bruna\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tNeuro-oncologia\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"mucinous_lmp_ovarian_tumour_intermed_mag\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tGrup Matias-Guiu\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tC\u00e0ncer ginecol\u00f2gic\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"envejecimiento-y-cancer\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tGrup Mu\u00f1oz\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tEnvelliment i c\u00e0ncer\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"Immunity-inflammation-and-cancer2\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tGrup Soler\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tImmunitat, inflamaci\u00f3 i c\u00e0ncer\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"transformaci\u00f3n\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tGrup Gonz\u00e1lez-Su\u00e1rez\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tTransformaci\u00f3 i met\u00e0stasi\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"\"\n\t\t\t\t<\/a>\n\t\t\t\t\"Purificacion-Mu\u00f1oz\"\n

\n\t\tMu\u00f1oz Moruno, Purificaci\u00f3n\n\t<\/h4>\n

\n\t\tCO-COORDINADORA DE PROGRAMA\n\t<\/h4>\n

\n\t\t\n\t\tp.munoz@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\"Josep-Maria-Piulats-Rodriguez\"\n

\n\t\tPiulats Rodriguez, Jose Maria\n\t<\/h4>\n

\n\t\tCO-COORDINADOR DE PROGRAMA\n\t<\/h4>\n

\n\t\t\n\t\tjpiulats@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n

\n\t\tAytes Meneses, Alvaro\n\t<\/h4>\n

\n\t\tCO-COORDINADOR DOCENT\n\t<\/h4>\n

\n\t\t\n\t\taaytes@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n

\n\t\tRodriguez Barrueco, Ruth\n\t<\/h4>\n

\n\t\tCO-COORDINADORA DOCENT\n\t<\/h4>\n

\n\t\t\n\t\trrodriguezb@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n

\n\t\tGrups ProCURE\n\t<\/h3>\n\t\t\t\t\n\t\t\t\t\"angiogenesis-tumoral\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tGrup Casanovas\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tAngiog\u00e8nesi Tumoral\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"viroterapia-del-cancer\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tGrup Alemany & Piulats\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tImmunoter\u00e0pia del c\u00e0ncer\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"quimioresistencia-y-xenografts-ortotopicos\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tGrup Garcia & Villanueva\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tQuimioresist\u00e8ncia tumoral i estromal\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"cancer-de-mama\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tGrup Pujana\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tC\u00e0ncer de mama\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"mecanismos-de-resistencia-y-progresion-en-el-cancer-de-prostata\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tGrup Aytes\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tMecanismes de resist\u00e8ncia i progressi\u00f3 en el c\u00e0ncer de pr\u00f2stata\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"senializacion-molecular\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tGrup Vi\u00f1als\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tSenyalitzaci\u00f3 molecular\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\"Miguel-Angel-Pujana\"\n

\n\t\tGenestar Pujana, Miguel \u00c1ngel\n\t<\/h4>\n

\n\t\tCOORDINADOR ProCURE\n\t<\/h4>\n

\n\t\t\n\t\tmgenestar@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n

\n\t\tNot\u00edcies relacionades\n\t<\/h3>\n\t\t\n\t\t\t\t<\/a>\n\t\t\tUna nova eina basada en la Intel\u2022lig\u00e8ncia Artificial permetr\u00e0 millorar el diagn\u00f2stic de tumors cerebrals<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t12\/03\/2024\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tL’Associaci\u00f3 Contra el C\u00e0ncer a Barcelona finan\u00e7a dos projectes de l’IDIBELL amb 445.000 euros<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t07\/03\/2024\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tSe celebra la primera Jornada d’Innovaci\u00f3 sobre el Diagn\u00f2stic i Tractament dels Pacients amb C\u00e0ncer de Pulm\u00f3 al Campus de Bellvitge<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t16\/02\/2024\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tUn f\u00e0rmac anticancer\u00f3s obre una nova via de tractament del Parkinson<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t09\/02\/2024\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tDescobreixen alteracions del sistema immunol\u00f2gic sanguini que augmenten el risc de c\u00e0ncer<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t06\/02\/2024\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tPresenten un virus oncol\u00edtic dirigit a c\u00e8l\u00b7lules NK amb gran potencial antitumoral<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t12\/01\/2024\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tDescobreixen un nou mecanisme que explica el desenvolupament de malformacions vasculars<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t11\/01\/2024\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tTroben com definir ter\u00e0pies dirigides en c\u00e0ncer de pulm\u00f3 gr\u00e0cies a una plataforma de seq\u00fcenciaci\u00f3 gen\u00e8tica<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t04\/01\/2024\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tLa intel\u00b7lig\u00e8ncia artificial ajuda a prendre decisions sobre el trasplantament de medul\u00b7la \u00f2ssia<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t21\/12\/2023\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tS’obre una nova via per combatre el c\u00e0ncer a trav\u00e9s del gen MYC<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t19\/12\/2023\t\t\t\t\t\t\t\n\t\t\n\n","protected":false},"excerpt":{"rendered":"

Programa de Mecanismes Moleculars i Ter\u00e0pia Experimental en Oncologia (Oncobell) Resum La recerca desenvolupada pels diferents grups del programa cobreix la major part de les etapes investigadores, des de la recerca b\u00e0sica a l’aplicaci\u00f3 cl\u00ednica. La millora del pron\u00f2stic del pacient \u00e9s un objectiu com\u00fa a qu\u00e8 s’intenta arribar o b\u00e9 des de l’estudi a […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":446,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"publishpress_future_action":{"enabled":false,"date":"2024-05-15 21:50:04","action":"change-status","newStatus":"draft","terms":[],"taxonomy":""},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/448"}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=448"}],"version-history":[{"count":6,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/448\/revisions"}],"predecessor-version":[{"id":25400,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/448\/revisions\/25400"}],"up":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/446"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=448"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}